Advanced search
Publication Cover
Modern Rheumatology Volume 27, 2017 - Issue 5
Journal homepage
183
Views
3
CrossRef citations to date
0
Altmetric
Original Article

Fcγ receptor 3B polymorphism is associated with hypersensitivity reactions to adalimumab in Japanese patients with rheumatoid arthritis

Masako TsukamotoDivision of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan and
,
Hideto KamedaDivision of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan and ;Division of Rheumatology, Department of Internal Medicine, School of Medicine, Toho University, Tokyo, Japan
,
Tatsuhiro OhshigeDivision of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan and
,
Yuko KanekoDivision of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan and
,
Keiko YoshimotoDivision of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan and
,
Katsuya SuzukiDivision of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan and
&
Tsutomu TakeuchiDivision of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan and Correspondence[email protected]
 show all
Pages 778-781 | Received 09 Aug 2016, Accepted 25 Oct 2016, Published online: 18 Nov 2016

References

  • Puxeddu I, Giori L, Rocchi V, Bazzichi L, Bombardieri S, Tavoni A, et al. Hypersensitivity reactions during treatment with infliximab, etanercept, and adalimumab. Ann Allergy Asthma Immunol. 2012;108(2):123–4. doi: 10.1016/j.anai.2011.11.004.
  • Benucci M, Manfredi M, Testi S, Iorno ML, Valentini M, Soldaini F, et al. Spondylarthritis presenting with an allergic immediate systemic reaction to adalimumab in a woman: a case report. J Med Case Rep. 2011;5:155. doi: 10.1186/1752-1947-5-155.
  • Okuyama A, Nagasawa H, Suzuki K, Kameda H, Kondo H, Amano K, et al. Fcγ receptor IIIb polymorphism and use of glucocorticoids at baseline are associated with infusion reactions to infliximab in patients with rheumatoid arthritis. Ann Rheum Dis. 2011;70(2):299–304. doi: 10.1136/ard.2010.136283.
  • Takai T. Roles of Fc receptors in autoimmunity. Nat Rev Immunol. 2002;2(8):580–92.
  • Morgan AW, Barrett JH, Griffiths B, Subramanian D, Robinson JI, Keyte VH, et al. Analysis of Fcgamma receptor haplotypes in rheumatoid arthritis: FCGR3A remains a major susceptibility gene at this locus, with an additional contribution from FCGR3B. Arthritis Res Ther. 2006;8(1):R5. doi: 10.1186/ar1847.
  • Chen JY, Wang CM, Wu JM, Ho HH, Luo SF. Association of rheumatoid factor production with FcgammaRIIIa polymorphism in Taiwanese rheumatoid arthritis. Clin Exp Immunol. 2006;144(1):10–6.
  • Ruyssen-Witrand A, Rouanet S, Combe B, Dougados M, Le Loët X, Sibilia J, et al. Fcγ receptor type IIIA polymorphism influences treatment outcomes in patients with rheumatoid arthritis treated with rituximab. Ann Rheum Dis. 2012;71(6):875–7. doi: 10.1136/annrheumdis-2011-200337.
  • Hernández MV, Sanmartí R, Cañete JD, Descalzo MA, Alsina M, Carmona L, et al. Cutaneous adverse events during treatment of chronic inflammatory rheumatic conditions with tumor necrosis factor antagonists: study using the Spanish registry of adverse events of biological therapies in rheumatic diseases. Arthritis Care Res (Hoboken). 2013;65(12):2024–31. doi: 10.1002/acr.22096.
  • Koike T, Harigai M, Ishiguro N, Inokuma S, Takei S, Takeuchi T, et al. Safety and effectiveness of adalimumab in Japanese rheumatoid arthritis patients: postmarketing surveillance report of the first 3,000 patients. Mod Rheumatol. 2012;22(4):498–508. doi: 10.1007/s10165-011-0541-5.
  • Van Den Berg L, Myhr KM, Kluge B, Vedeler CA. Fcgamma receptor polymorphisms in populations in Ethiopia and Norway. Immunology. 2001;104(1):87–91.
  • Torkildsen O, Utsi E, Mellgren SI, Harbo HF, Vedeler CA, Myhr KM. Ethnic variation of Fc gamma receptor polymorphism in Sami and Norwegian populations. Immunology. 2005;115(3):416–21.
  • van Schie RC, Wilson ME. Evaluation of human FcgammaRIIA (CD32) and FcgammaRIIIB (CD16) polymorphisms in Caucasians and African-Americans using salivary DNA. Clin Diagn Lab Immunol. 2000;7(4):676–81.
  • Hong CH, Lee JS, Lee HS, Bae SC, Yoo DH. The association between fcgammaRIIIB polymorphisms and systemic lupus erythematosus in Korea. Lupus. 2005;14(5):346–50.
  • Kyogoku C, Dijstelbloem HM, Tsuchiya N, Hatta Y, Kato H, Yamaguchi A, et al. Fcgamma receptor gene polymorphisms in Japanese patients with systemic lupus erythematosus: contribution of FCGR2B to genetic susceptibility. Arthritis Rheum. 2002;46(5):1242–54.
  • Covas DT, Kashima S, Guerreiro JF, dos Santos SE, Zago MA. Variation in the FcgammaR3B gene among distinct Brazilian populations. Tissue Antigens. 2005;65(2):178–82.
  • Pichler WJ. Adverse side-effects to biological agents. Allergy. 2006; 61(8):912–20.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.